undamentalytics Newsletter

Infusystem Holdings, Inc cash flow statement

In fiscal 2025, Infusystem Holdings, Inc's operations generated $24.4m of cash; it spent $560,000 on capital projects, leaving free cash flow of $23.8m. It returned $9.9m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Infusystem Holdings, Inc: cash flow statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations10117577788111420181811202423
Depreciation and amortisation456654577111214151313121313
Stock-based pay141111101113644445
Capital spending528752000031111110
Free cash flow58−1−135788111119171710192423
Free cash flow after stock pay45−3−22567710101711136151918
Share buybacks—0000000—10001501108

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: INFU vs STIMINFU vs RXSTBBNX vs INFU

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Infusystem Holdings, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Infusystem Holdings, Inc.